Emi Sei
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 17
-
- Single-cell and spatial transcriptomics 12
- Epigenetics and DNA Methylation 2
- Gene expression and cancer classification 2
- Co-authors
- Nicholas E. Navin (22 shared papers)Ruli Gao (9 shared papers)Charissa Kim (3 shared papers)Theodoros Foukakis (2 shared papers)Nicola Crosetto (2 shared papers)Thomas Hatschek (1 shared paper)Rachel Brandt (1 shared paper)Johan Hartman (1 shared paper)
- Journals
- Cancer Research (5 papers)Cell (3 papers)Nature Biotechnology (2 papers)Cell Genomics (2 papers)Molecular Cell (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Emi Sei
24 papers receiving 2.6k citations
Emi Sei's Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 1.2k
- Oncology 848
- Molecular Biology 1.5k
- Biophysics 108
- Immunology 274
Countries citing papers authored by Emi Sei
This map shows the geographic impact of Emi Sei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Sei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Sei more than expected).
Fields of papers citing papers by Emi Sei
This network shows the impact of papers produced by Emi Sei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Sei. The network helps show where Emi Sei may publish in the future.
Co-authors
The 25 scholars most cited alongside Emi Sei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing Hit paper breakdown → | 2018 | 713 |
| 2 | Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes Hit paper breakdown → | 2021 | 468 |
| 3 | 2016 | 315 | |
| 4 | 2018 | 290 | |
| 5 | 2017 | 148 | |
| 6 | 2022 | 144 | |
| 7 | 2019 | 121 | |
| 8 | 2017 | 86 | |
| 9 | 2020 | 63 | |
| 10 | 2022 | 45 | |
| 11 | 2016 | 36 | |
| 12 | 2022 | 29 | |
| 13 | 2011 | 28 | |
| 14 | 2021 | 24 | |
| 15 | 2015 | 19 | |
| 16 | 2013 | 14 | |
| 17 | 2014 | 12 | |
| 18 | 2020 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2025 | 4 |
About Emi Sei
Emi Sei is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 26 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (17 papers), Single-cell and spatial transcriptomics (12 papers), Prostate Cancer Treatment and Research (5 papers), Viral-associated cancers and disorders (3 papers), Cancer Cells and Metastasis (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Epigenetics and DNA Methylation (2 papers) and Gene expression and cancer classification (2 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (848 citations), Molecular Biology (1.5k citations), Biophysics (108 citations) and Immunology (274 citations). Emi Sei has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Nicholas E. Navin, Ruli Gao, Charissa Kim, Theodoros Foukakis, Nicola Crosetto, Thomas Hatschek, Rachel Brandt, Johan Hartman, Tod D. Casasent and Funda Meric‐Bernstam. Their work appears in journals such as Cancer Research, Cell, Nature Biotechnology, Cell Genomics and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.